Should SARS-CoV-2 influence immunosuppressive therapy for autoimmune blistering diseases?
Identifieur interne : 000190 ( PubMed/Checkpoint ); précédent : 000189; suivant : 000191Should SARS-CoV-2 influence immunosuppressive therapy for autoimmune blistering diseases?
Auteurs : Ambra Di Altobrando [Italie] ; Annalisa Patrizi [Italie] ; Federico Bardazzi [Italie]Source :
- Journal of the European Academy of Dermatology and Venereology : JEADV [ 1468-3083 ] ; 2020.
Abstract
In this dramatic period where the whole world is affected by the outbreak of coronavirus disease 19 (COVID-19), scientific data relating to the causative virus SARS-CoV-2 as well as the subsequent therapeutic repercussions on the management of other diseases should be divulged in order to share as much information as possible among experts in a timely manner.
DOI: 10.1111/jdv.16491
PubMed: 32302437
Affiliations:
Links toward previous steps (curation, corpus...)
Links to Exploration step
pubmed:32302437Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Should SARS-CoV-2 influence immunosuppressive therapy for autoimmune blistering diseases?</title><author><name sortKey="Di Altobrando, Ambra" sort="Di Altobrando, Ambra" uniqKey="Di Altobrando A" first="Ambra" last="Di Altobrando">Ambra Di Altobrando</name><affiliation wicri:level="1"><nlm:affiliation>Department of Experimental, Diagnostic and Specialty Medicine - Division of Dermatology, University of Bologna, Bologna, Italy.</nlm:affiliation><country xml:lang="fr">Italie</country><wicri:regionArea>Department of Experimental, Diagnostic and Specialty Medicine - Division of Dermatology, University of Bologna, Bologna</wicri:regionArea><wicri:noRegion>Bologna</wicri:noRegion></affiliation></author><author><name sortKey="Patrizi, Annalisa" sort="Patrizi, Annalisa" uniqKey="Patrizi A" first="Annalisa" last="Patrizi">Annalisa Patrizi</name><affiliation wicri:level="1"><nlm:affiliation>Department of Experimental, Diagnostic and Specialty Medicine - Division of Dermatology, University of Bologna, Bologna, Italy.</nlm:affiliation><country xml:lang="fr">Italie</country><wicri:regionArea>Department of Experimental, Diagnostic and Specialty Medicine - Division of Dermatology, University of Bologna, Bologna</wicri:regionArea><wicri:noRegion>Bologna</wicri:noRegion></affiliation></author><author><name sortKey="Bardazzi, Federico" sort="Bardazzi, Federico" uniqKey="Bardazzi F" first="Federico" last="Bardazzi">Federico Bardazzi</name><affiliation wicri:level="1"><nlm:affiliation>Department of Experimental, Diagnostic and Specialty Medicine - Division of Dermatology, University of Bologna, Bologna, Italy.</nlm:affiliation><country xml:lang="fr">Italie</country><wicri:regionArea>Department of Experimental, Diagnostic and Specialty Medicine - Division of Dermatology, University of Bologna, Bologna</wicri:regionArea><wicri:noRegion>Bologna</wicri:noRegion></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2020">2020</date><idno type="RBID">pubmed:32302437</idno><idno type="pmid">32302437</idno><idno type="doi">10.1111/jdv.16491</idno><idno type="wicri:Area/PubMed/Corpus">000051</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000051</idno><idno type="wicri:Area/PubMed/Curation">000051</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000051</idno><idno type="wicri:Area/PubMed/Checkpoint">000190</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000190</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Should SARS-CoV-2 influence immunosuppressive therapy for autoimmune blistering diseases?</title><author><name sortKey="Di Altobrando, Ambra" sort="Di Altobrando, Ambra" uniqKey="Di Altobrando A" first="Ambra" last="Di Altobrando">Ambra Di Altobrando</name><affiliation wicri:level="1"><nlm:affiliation>Department of Experimental, Diagnostic and Specialty Medicine - Division of Dermatology, University of Bologna, Bologna, Italy.</nlm:affiliation><country xml:lang="fr">Italie</country><wicri:regionArea>Department of Experimental, Diagnostic and Specialty Medicine - Division of Dermatology, University of Bologna, Bologna</wicri:regionArea><wicri:noRegion>Bologna</wicri:noRegion></affiliation></author><author><name sortKey="Patrizi, Annalisa" sort="Patrizi, Annalisa" uniqKey="Patrizi A" first="Annalisa" last="Patrizi">Annalisa Patrizi</name><affiliation wicri:level="1"><nlm:affiliation>Department of Experimental, Diagnostic and Specialty Medicine - Division of Dermatology, University of Bologna, Bologna, Italy.</nlm:affiliation><country xml:lang="fr">Italie</country><wicri:regionArea>Department of Experimental, Diagnostic and Specialty Medicine - Division of Dermatology, University of Bologna, Bologna</wicri:regionArea><wicri:noRegion>Bologna</wicri:noRegion></affiliation></author><author><name sortKey="Bardazzi, Federico" sort="Bardazzi, Federico" uniqKey="Bardazzi F" first="Federico" last="Bardazzi">Federico Bardazzi</name><affiliation wicri:level="1"><nlm:affiliation>Department of Experimental, Diagnostic and Specialty Medicine - Division of Dermatology, University of Bologna, Bologna, Italy.</nlm:affiliation><country xml:lang="fr">Italie</country><wicri:regionArea>Department of Experimental, Diagnostic and Specialty Medicine - Division of Dermatology, University of Bologna, Bologna</wicri:regionArea><wicri:noRegion>Bologna</wicri:noRegion></affiliation></author></analytic><series><title level="j">Journal of the European Academy of Dermatology and Venereology : JEADV</title><idno type="eISSN">1468-3083</idno><imprint><date when="2020" type="published">2020</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">In this dramatic period where the whole world is affected by the outbreak of coronavirus disease 19 (COVID-19), scientific data relating to the causative virus SARS-CoV-2 as well as the subsequent therapeutic repercussions on the management of other diseases should be divulged in order to share as much information as possible among experts in a timely manner.</div></front></TEI><pubmed><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">32302437</PMID><DateRevised><Year>2020</Year><Month>04</Month><Day>17</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1468-3083</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2020</Year><Month>Apr</Month><Day>17</Day></PubDate></JournalIssue><Title>Journal of the European Academy of Dermatology and Venereology : JEADV</Title><ISOAbbreviation>J Eur Acad Dermatol Venereol</ISOAbbreviation></Journal><ArticleTitle>Should SARS-CoV-2 influence immunosuppressive therapy for autoimmune blistering diseases?</ArticleTitle><ELocationID EIdType="doi" ValidYN="Y">10.1111/jdv.16491</ELocationID><Abstract><AbstractText>In this dramatic period where the whole world is affected by the outbreak of coronavirus disease 19 (COVID-19), scientific data relating to the causative virus SARS-CoV-2 as well as the subsequent therapeutic repercussions on the management of other diseases should be divulged in order to share as much information as possible among experts in a timely manner.</AbstractText><CopyrightInformation>This article is protected by copyright. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Di Altobrando</LastName><ForeName>Ambra</ForeName><Initials>A</Initials><Identifier Source="ORCID">https://orcid.org/0000-0003-3236-8822</Identifier><AffiliationInfo><Affiliation>Department of Experimental, Diagnostic and Specialty Medicine - Division of Dermatology, University of Bologna, Bologna, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Patrizi</LastName><ForeName>Annalisa</ForeName><Initials>A</Initials><Identifier Source="ORCID">https://orcid.org/0000-0002-8398-0483</Identifier><AffiliationInfo><Affiliation>Department of Experimental, Diagnostic and Specialty Medicine - Division of Dermatology, University of Bologna, Bologna, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bardazzi</LastName><ForeName>Federico</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Experimental, Diagnostic and Specialty Medicine - Division of Dermatology, University of Bologna, Bologna, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016422">Letter</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>04</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Eur Acad Dermatol Venereol</MedlineTA><NlmUniqueID>9216037</NlmUniqueID><ISSNLinking>0926-9959</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">blistering disorders</Keyword><Keyword MajorTopicYN="N">bullous disorders</Keyword><Keyword MajorTopicYN="N">immunosuppressive therapy</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>4</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>4</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>4</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32302437</ArticleId><ArticleId IdType="doi">10.1111/jdv.16491</ArticleId></ArticleIdList></PubmedData></pubmed><affiliations><list><country><li>Italie</li></country></list><tree><country name="Italie"><noRegion><name sortKey="Di Altobrando, Ambra" sort="Di Altobrando, Ambra" uniqKey="Di Altobrando A" first="Ambra" last="Di Altobrando">Ambra Di Altobrando</name></noRegion><name sortKey="Bardazzi, Federico" sort="Bardazzi, Federico" uniqKey="Bardazzi F" first="Federico" last="Bardazzi">Federico Bardazzi</name><name sortKey="Patrizi, Annalisa" sort="Patrizi, Annalisa" uniqKey="Patrizi A" first="Annalisa" last="Patrizi">Annalisa Patrizi</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/PubMed/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000190 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd -nk 000190 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= SrasV1
|flux= PubMed
|étape= Checkpoint
|type= RBID
|clé= pubmed:32302437
|texte= Should SARS-CoV-2 influence immunosuppressive therapy for autoimmune blistering diseases?
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/RBID.i -Sk "pubmed:32302437" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd \
| NlmPubMed2Wicri -a SrasV1
| This area was generated with Dilib version V0.6.33. |  |